MicroPort<sup>®</sup> CRM Announces European Launch of New Tablet Programmer for Implantable Cardiac Devices

Clamart, France – January 21st, 2018 - MicroPort® CRM (a business unit of MicroPort Scientific Corporation), is pleased to announce the European launch of Smart Touch™, a totally new tablet-based programmer.
 
Pacemakers, implantable defibrillators and cardiac resynchronization devices require individual programming at implant and during follow-up visits, enabling the device settings to be regularly adapted and tailored to suit the needs of each patient.
 
The programmer is used by the physician or nurse to interact with the device via inductive telemetry or RF wireless connectivity. Up till now, programmers have been cumbersome, heavy pieces of equipment requiring hospital trolleys to transport them, limiting efficiency and mobility.
 
To enhance mobility and flexibility, the Smart Touch™ programmer has a light-weight tablet design. Physicians can use the Smart Touch™ tablet either directly in its docking station or in a hand-held fashion at the patient's bedside. The new battery-powered tablet removes unnecessary power cables providing much better freedom and mobility to physicians as well as an improved follow-up experience for patients.
 
Smart Touch™ also features Bluetooth technology to facilitate wireless connection with accessories such as printers or ECG equipment for greater efficiency and speed.
 
"I am impressed by this new tablet programmer," commented Dr. Vincent Ganière of the Hôpital Saint Loup, the first user of Smart Touch™ in Switzerland. "It's the first time I've seen a solution like this, it's very intuitive."
 
"With the Smart Touch™ tablet programmer we are providing our customers with a high-tech, modern tool that is more in line with their needs, facilitating programming and speeding up the follow-up of our implantable devices. Our goal with Smart Touch™ is to bring more comfort into daily practice and enhance the overall follow-up experience for physicians and patients alike", commented Benoit Clinchamps, President of MicroPort® CRM.

 

About MicroPort® CRM
 
Pioneering physiological therapies in cardiac rhythm management. Driven by our expert R&D teams and state-of-the-art manufacturing facilities across the globe, MicroPort® CRM conceives, designs and develops solutions for the management of cardiac rhythm disorders and heart failure. Headquartered in Paris, our precise technologies are manufactured in France, Italy, the Dominican Republic; and for the Chinese market, in China. MicroPort® CRM is part of MicroPort Scientific Corporation.
 
For more information visit www.crm.microport.com